Search Results - subject:"Drug Development"

A Breath of Fresh Air? Firm types, scale, scope and selection effects in drug development

Arora, Ashish; Gambardella, Alfonso; Magazzini, Laura; … - Volkswirtschaftliche Fakultät, … - 2007

drug development, which we use to estimate a structural model, using data on 3,000 drug R&D projects in preclinical and …

Persistent link: https://www.econbiz.de/10005061689

The Future of Drug Development: the Economics of Pharmacogenomics

Vernon, John A.; Hughen, W. Keener - eSocialSciences - 2006

predict drug response, may impact drug development times, attrition rates, costs,and the future returns to research and … expected drug development costs (via higher probabilities of technical success, shorter clinical development times, and smaller …

Persistent link: https://www.econbiz.de/10005487741

An empirical model of drug pricing and competition: a dynamic perspective

Camejo, Rodrigo Refoios; McGrath, Clare; Rutten, Frans F.H. - In: International Journal of Economics and Business Research 6 (2013) 2, pp. 173-193

In this study we test the impact of competition and other market attributes on the pricing of pharmaceuticals. Three decades worth of market and pricing data were collected and the market for lipid-lowering agents used as a case study. Panel data and cross sectional methods were applied to...

Persistent link: https://www.econbiz.de/10010684350

An empirical model of drug pricing and competition : a dynamic perspective

Camejo, Rodrigo Refoios; McGrath, Clare; Rutten, F. F. H. - In: International journal of economics and business research 6 (2013) 2, pp. 173-193

Persistent link: https://www.econbiz.de/10010351165

Contract research organizations: an industry analysis

Dimachkie Masri, Maysoun; Ramirez, Bernardo; Popescu, … - In: International Journal of Pharmaceutical and Healthcare … 6 (2012) 4, pp. 336-350

their emergence, growth, and evolution to date. Findings – The authors discuss the drug development process, the role of …/evolution of these organizations, with challenges as they become an integral part of the drug development process in the USA and …

Persistent link: https://www.econbiz.de/10014795882

Clinical trial excellence in the pharmaceutical industry : an integrated management model

Volkmer, Niels-Christian - 2010

Persistent link: https://www.econbiz.de/10008936034

A Breath of Fresh Air? Firm Type, Scale, Scope and Selection Effects in Drug Development.

Arora, Ashish; Gambardella, Alfonso; Magazzini, Laura; … - KITeS, Centre for Knowledge, Internationalization and … - 2009

This paper compares the innovation performance of established pharmaceutical firms and biotech companies, controlling for differences in the scale and scope of research. We develop a structural model to analyze more than 3,000 drug R&D projects advanced to pre-clinical and clinical trials in the...

Persistent link: https://www.econbiz.de/10008501715

A Breath of Fresh Air? Firm Type, Scale, Scope, and Selection Effects in Drug Development

Arora, Ashish; Gambardella, Alfonso; Magazzini, Laura; … - In: Management Science 55 (2009) 10, pp. 1638-1653

This paper compares the innovation performance of established pharmaceutical firms and biotech companies, controlling for differences in the scale and scope of research. We develop a structural model to analyze more than 3,000 drug research and development projects advanced to preclinical and...

Persistent link: https://www.econbiz.de/10009191729

Estimating new product uptake with the use of system dynamics

Ambroz, Kristjan - 2009

Persistent link: https://www.econbiz.de/10003816609

Valuation in life sciences : a practical guide

Bogdan, Boris; Villiger, Ralph - 2008 - 2. ed.

Persistent link: https://www.econbiz.de/10003643192